Cargando…
Transcatheter mitral and tricuspid interventions—the bigger picture: valvular disease as part of heart failure
The prevalence of mitral (MR) and tricuspid regurgitation (TR), especially in heart failure (HF) populations, is high. However, the distinct role of atrioventricular valve diseases in HF, whether they are merely indicators of disease status or rather independent contributors in a vicious disease cyc...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10225583/ https://www.ncbi.nlm.nih.gov/pubmed/37255703 http://dx.doi.org/10.3389/fcvm.2023.1091309 |
_version_ | 1785050405540986880 |
---|---|
author | Curio, Jonathan Beneduce, Alessandro Giannini, Francesco |
author_facet | Curio, Jonathan Beneduce, Alessandro Giannini, Francesco |
author_sort | Curio, Jonathan |
collection | PubMed |
description | The prevalence of mitral (MR) and tricuspid regurgitation (TR), especially in heart failure (HF) populations, is high. However, the distinct role of atrioventricular valve diseases in HF, whether they are merely indicators of disease status or rather independent contributors in a vicious disease cycle, is still not fully understood. For decades, tricuspid regurgitation (TR) was considered an innocent bystander subsequent to other heart or lung pathologies, thus, not needing dedicated treatment. Recent increasing awareness towards the role of atrioventricular valve diseases has revealed that MR and TR are, in fact, independent predictors of outcome in HF, thus, warranting attention in the HF treatment algorithm. This awareness arose, especially, with the development of minimally invasive transcatheter solutions providing new treatment options, which can also be used for patients considered as having increased surgical risk. However, outcomes of such transcatheter treatments have, in part, been sub-optimal and likely influenced by the status of the concomitant HF disease. Thus, this review aims to summarize data on the current understanding regarding the role of MR and TR in HF, how HF impacts outcomes of transcatheter MR and TR interventions, and how the understanding of this relationship might help to identify patients that benefit most from these therapies, which have proven to be lifesaving in properly selected candidates. |
format | Online Article Text |
id | pubmed-10225583 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-102255832023-05-30 Transcatheter mitral and tricuspid interventions—the bigger picture: valvular disease as part of heart failure Curio, Jonathan Beneduce, Alessandro Giannini, Francesco Front Cardiovasc Med Cardiovascular Medicine The prevalence of mitral (MR) and tricuspid regurgitation (TR), especially in heart failure (HF) populations, is high. However, the distinct role of atrioventricular valve diseases in HF, whether they are merely indicators of disease status or rather independent contributors in a vicious disease cycle, is still not fully understood. For decades, tricuspid regurgitation (TR) was considered an innocent bystander subsequent to other heart or lung pathologies, thus, not needing dedicated treatment. Recent increasing awareness towards the role of atrioventricular valve diseases has revealed that MR and TR are, in fact, independent predictors of outcome in HF, thus, warranting attention in the HF treatment algorithm. This awareness arose, especially, with the development of minimally invasive transcatheter solutions providing new treatment options, which can also be used for patients considered as having increased surgical risk. However, outcomes of such transcatheter treatments have, in part, been sub-optimal and likely influenced by the status of the concomitant HF disease. Thus, this review aims to summarize data on the current understanding regarding the role of MR and TR in HF, how HF impacts outcomes of transcatheter MR and TR interventions, and how the understanding of this relationship might help to identify patients that benefit most from these therapies, which have proven to be lifesaving in properly selected candidates. Frontiers Media S.A. 2023-05-15 /pmc/articles/PMC10225583/ /pubmed/37255703 http://dx.doi.org/10.3389/fcvm.2023.1091309 Text en © 2023 Curio, Beneduce and Giannini. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) (https://creativecommons.org/licenses/by/4.0/) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cardiovascular Medicine Curio, Jonathan Beneduce, Alessandro Giannini, Francesco Transcatheter mitral and tricuspid interventions—the bigger picture: valvular disease as part of heart failure |
title | Transcatheter mitral and tricuspid interventions—the bigger picture: valvular disease as part of heart failure |
title_full | Transcatheter mitral and tricuspid interventions—the bigger picture: valvular disease as part of heart failure |
title_fullStr | Transcatheter mitral and tricuspid interventions—the bigger picture: valvular disease as part of heart failure |
title_full_unstemmed | Transcatheter mitral and tricuspid interventions—the bigger picture: valvular disease as part of heart failure |
title_short | Transcatheter mitral and tricuspid interventions—the bigger picture: valvular disease as part of heart failure |
title_sort | transcatheter mitral and tricuspid interventions—the bigger picture: valvular disease as part of heart failure |
topic | Cardiovascular Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10225583/ https://www.ncbi.nlm.nih.gov/pubmed/37255703 http://dx.doi.org/10.3389/fcvm.2023.1091309 |
work_keys_str_mv | AT curiojonathan transcathetermitralandtricuspidinterventionsthebiggerpicturevalvulardiseaseaspartofheartfailure AT beneducealessandro transcathetermitralandtricuspidinterventionsthebiggerpicturevalvulardiseaseaspartofheartfailure AT gianninifrancesco transcathetermitralandtricuspidinterventionsthebiggerpicturevalvulardiseaseaspartofheartfailure |